CUSIP: 84763AAB4
What is CUSIP 84763AAB4?
CUSIP 84763AAB4 identifies 84763AAB4 - SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 84763AAB4:
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2019 Q1 | $0 | $0 | -$38,000 | 0 | |
| 2018 Q4 | $23,000 | $38,000 | -$50,740,000 | 165.22% | 1 |
| 2018 Q3 | $31,539,000 | $50,778,000 | -$9,059,406 | 161.33% | 6 |
| 2018 Q2 | $35,999,000 | $72,485,000 | +$3,814,977 | 200.78% | 7 |
| 2018 Q1 | $36,084,000 | $57,418,064 | +$333,322 | 160.0% | 8 |
| 2017 Q4 | $35,934,000 | $66,778,279 | -$102,030,902 | 185.6% | 9 |
| 2017 Q3 | $103,974,000 | $147,230,858 | +$16,102,467 | 141.69% | 13 |
| 2017 Q2 | $93,148,000 | $98,061,651 | +$94,988 | 105.85% | 14 |
| 2017 Q1 | $93,117,000 | $94,480,726 | -$3,621,197 | 100.93% | 15 |
| 2016 Q4 | $99,318,000 | $90,412,879 | -$8,423,975 | 89.59% | 16 |
| 2016 Q3 | $108,801,000 | $97,827,107 | -$811,158 | 89.63% | 18 |
| 2016 Q2 | $109,689,731 | $101,597,872 | -$1,460,957 | 92.31% | 16 |
| 2016 Q1 | $110,601,000 | $98,286,261 | -$25,949 | 88.68% | 18 |
| 2015 Q4 | $133,454,000 | $116,958,000 | +$2,858,440 | 87.65% | 18 |
| 2015 Q3 | $112,076,000 | $100,398,000 | +$1,220,984 | 89.61% | 20 |
| 2015 Q2 | $101,671,000 | $95,726,000 | -$1,242,191 | 94.03% | 18 |
| 2015 Q1 | $102,982,000 | $94,559,000 | +$77,073,000 | 91.82% | 18 |